IN2013MU01244A - - Google Patents
Info
- Publication number
- IN2013MU01244A IN2013MU01244A IN1244MU2013A IN2013MU01244A IN 2013MU01244 A IN2013MU01244 A IN 2013MU01244A IN 1244MU2013 A IN1244MU2013 A IN 1244MU2013A IN 2013MU01244 A IN2013MU01244 A IN 2013MU01244A
- Authority
- IN
- India
- Prior art keywords
- methylphenidate
- salts
- release
- composition
- pharmaceutical compositions
- Prior art date
Links
Abstract
The present invention relates to modified release pharmaceutical compositions of methylphenidate or salts thereof. In particular, the present invention relates to modified release pharmaceutical compositions comprising at least one immediate release and at least one extended release component of methylphenidate or salts thereof. The composition may provide extended and specific release of methylphenidate or salts thereof to achieve therapeutically effective plasma concentration over a period of 12 hours to treat attention deficit disorders when administered to a patient in need thereof. The invention also includes process of preparing such composition.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN1244MU2013 IN2013MU01244A (en) | 2013-03-29 | 2014-03-24 | |
PCT/IB2014/060084 WO2014174388A1 (en) | 2013-03-29 | 2014-03-24 | Modified release pharmaceutical compositions of methylphenidate or salts thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN1244MU2013 IN2013MU01244A (en) | 2013-03-29 | 2014-03-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2013MU01244A true IN2013MU01244A (en) | 2015-04-17 |
Family
ID=54395636
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN1244MU2013 IN2013MU01244A (en) | 2013-03-29 | 2014-03-24 |
Country Status (1)
Country | Link |
---|---|
IN (1) | IN2013MU01244A (en) |
-
2014
- 2014-03-24 IN IN1244MU2013 patent/IN2013MU01244A/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12019502355A1 (en) | Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis b | |
MX2013011908A (en) | Compositions and therapeutic uses of ikk-related kinase epsilon and tankbinding kinase 1 inhibitors. | |
IN2015DN01156A (en) | ||
PH12015500724B1 (en) | 1, 2, 4-triazine derivatives for the treatment of viral infections | |
MX2013012053A (en) | Inhibitors of viral replication, their process of preparation and their therapeutical uses. | |
MX2013011691A (en) | Inhibitors of viral replication, their process of preparation and their therapeutical uses. | |
MX367926B (en) | Pharmaceutical composition for a sustained release of lanreotide. | |
MX2013002118A (en) | Substituted 2-oxy-quinoline-3-carboxamides as kcnq2/3 modulators. | |
MX2015005733A (en) | Tricyclic compounds for use in the treatment and/or control of obesity. | |
IN2014DN09437A (en) | ||
MX364704B (en) | Inhibitors of viral replication, their process of preparation and their therapeutical uses. | |
GB201115977D0 (en) | Neurodevelopmental disorders | |
MX2013002295A (en) | Substituted 1-oxo-dihydroisoquinoline-3-carboxamides as kcnq2/3 modulators. | |
IN2013MU01249A (en) | ||
IN2013MU01248A (en) | ||
IN2013MU01247A (en) | ||
IN2013MU01246A (en) | ||
IN2013MU01244A (en) | ||
IN2013MU01245A (en) | ||
IN2013MU01250A (en) | ||
IN2013MU01241A (en) | ||
IN2013MU01242A (en) | ||
IN2013MU01240A (en) | ||
IN2013MU01243A (en) | ||
IN2013MU01239A (en) |